3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Sleep Initiation and Maintenance Disorders
30
Neoplasms
22
Breast Neoplasms
20
Anxiety Disorders
13
Depression
12
Prostatic Neoplasms
8
Fatigue
8
Motor Activity
4
Lymphoma
4
Lung Neoplasms
4
Weight Loss
3
Uterine Cervical Neoplasms
3
Ovarian Neoplasms
3
Melanoma
3
Colorectal Neoplasms
3
Chronic Pain
3
Smoking Cessation
2
Sleep Wake Disorders
2
Pain
2
Overweight
2
Obesity
2
Nervous System Diseases
2
Multiple Myeloma
2
Lymphoma, Follicular
2
Glioma
2
Glioblastoma
2
Cognitive Dysfunction
2
Carcinoma, Non-Small-Cell Lung
2
Weight Gain
1
Uterine Neoplasms
1
Interventions
Temozolomide
44
Radiotherapy
20
Magnetic Resonance Spectroscopy
13
Irinotecan
13
Carboplatin
11
Bevacizumab
11
Filgrastim
9
Surgical Procedures, Operative
7
Procarbazine
6
sargramostim
5
Vincristine
5
Imatinib Mesylate
5
Etoposide
5
Erlotinib Hydrochloride
5
Carmustine
5
Biopsy
5
etoposide phosphate
4
Peripheral Blood Stem Cell Transplantation
4
Lomustine
4
Immunohistochemistry
4
Cyclophosphamide
4
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
4
temsirolimus
3
poly ICLC
3
aldesleukin
3
Thalidomide
3
Surveys and Questionnaires
3
Radiation
3
Polymerase Chain Reaction
3
Gadolinium DTPA
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Oligodendroglioma
×
Cognitive Behavioral Therapy
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled